Published by
@ShahidNShah
@ShahidNShah
51-200Hospitals and Health Care
108 1st St, Los Altos, California, 94022, United States
ArteraAI specializes in prognosticating patient outcomes and tailoring treatment for localized prostate cancer. Leveraging five Phase III randomized trials, it pioneers AI biomarkers for precision medicine. The ArteraAI Prostate Test predicts therapy benefits from biopsy images, fostering confident treatment decisions. Committed to personalized cancer care, ArteraAI aims for informed, confident decisions through AI-driven support for clinicians and patients.
ArteraAI pioneers AI-driven precision therapy in cancer care, leveraging prostate cancer biomarkers for enhanced clinical decisions. By harnessing extensive clinical data and digital pathology images, …
Posted Cancer Artificial Intelligence
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 13, 2024 at 3:24pm